IL-6 is required for airway mucus production induced by inhaled fungal allergens

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 1732-1738

  Neveu, Wendy A ^a   Allard, Jenna B ^a   Dienz, Oliver ^a   Wargo, Matthew J ^a   Ciliberto, Gennaro ^b   Whittaker, Laurie A ^a   Rincon, Mercedes ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD4 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 6; FUNGUS ANTIGEN; MUCIN;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; INFLAMMATION; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; HYPERSENSITIVITY; IMMUNOLOGY; MUCUS; PATHOLOGY; RESPIRATORY SYSTEM; SECRETION;

ALLERGENS; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS FUMIGATUS; EPITHELIAL CELLS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-6; MICE; MUCINS; MUCUS; RESPIRATORY SYSTEM;

EID: 68149183241     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802923     Document Type: Article

References (61)

1. Kishimoto, T. 2005. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23: 1-21.
2. Diehl, S., J. Anguita, A. Hoffmeyer, T. Zapton, J. N. Ihle, E. Fikrig, and M. Rincon. 2000. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 804-815.
3. Diehl, S., C. W. Chow, L. Weiss, A. Palmetshofer, T. Twardzik, L. Rounds, E. Serfling, R. J. Davis, J. Anguita, and M. Rincon. 2002. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196: 39-49.
4. Yang, Y., J. Ochando, A. Yopp, J. S. Bromberg, and Y. Ding. 2005. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J. Immunol. 174: 2720-2729. (Pubitemid 40279687)
5. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
6. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
7. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441: 231-234.
8. Dominitzki, S., M. C. Fantini, C. Neufert, A. Nikolaev, P. R. Galle, J. Scheller, G. Monteleone, S. Rose-John, M. F. Neurath, and C. Becker. 2007. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J. Immunol. 179: 2041-2045.
9. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
10. Berton, M. T., J. W. Uhr, and E. S. Vitetta. 1989. Synthesis of germ-line γ1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon γ. Proc. Nat. Acad. Sci. USA 86: 2829-2833.
11. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
12. Whittaker, L., N. Niu, U. A. Temann, A. Stoddard, R. A. Flavell, A. Ray, R. J. Homer, and L. Cohn. 2002. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am. J. Respir. Cell Mol. Biol. 27: 593-602.
13. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
14. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167: 4668-4675.
15. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
16. Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203: 2715-2725.
17. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
18. Virchow, J. C., Jr., C. Walker, D. Hafner, C. Kortsik, P. Werner, H. Matthys, and C. Kroegel. 1995. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 151: 960-968.
19. Yokoyama, A., N. Kohno, S. Fujino, H. Hamada, Y. Inoue, S. Fujioka, S. Ishida, and K. Hiwada. 1995. Circulating interleukin-6 levels in patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 151: 1354-1358.
20. Marini, M., E. Vittori, J. Hollemborg, and S. Mattoli. 1992. Expression of potent inflammatory cytokines, granulocytic-macrophage-colony-stimulating factor and interleukin-6 in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89: 1001-1009.
21. Wang, J., R. J. Homer, Q. Chen, and J. A. Elias. 2000. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165: 4051-4061. (Pubitemid 32063095)
22. Qiu, Z., M. Fujimura, K. Kurashima, S. Nakao, and N. Mukaida. 2004. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen. Clin. Exp. Allergy 34: 1321-1328.
23. Doganci, A., T. Eigenbrod, N. Krug, G. T. De Sanctis, M. Hausding, V. J. Erpenbeck, el-B. Haddad, H. A. Lehr, E. Schmitt, T. Bopp, et al. 2005. The IL-6Rα chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115: 313-325.
24. Latge, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12: 310-350.
25. Poli, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G. A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13: 1189-1196.
26. Dienz, O., S. M. Eaton, J. P. Bond, W. Neveu, D. Moquin, R. Noubade, E. M. Briso, C. Charland, W. J. Leonard, G. Ciliberto, et al. 2009. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206: 69-78.
27. Allard, J. B., M. E. Poynter, K. A. Marr, L. Cohn, M. Rincon, and L. A. Whittaker. 2006. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 177: 5186-5194.
28. Poynter, M. E., C. G. Irvin, and Y. M. Janssen-Heininger. 2003. A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 170: 6257-6265.
29. Bettiol, J., J. Sele, M. Henket, E. Louis, M. Malaise, P. Bartsch, and R. Louis. 2002. Cytokine production from sputum cells after allergenic challenge in IgEmediated asthma. Allergy 57: 1145-1150.
30. Green, B. J., T. Z. Mitakakis, and E. R. Tovey. 2003. Allergen detection from 11 fungal species before and after germination. J. Allergy Clin. Immunol. 111: 285-289.
31. Bao, L., Y. Zhu, A. M. Elhassan, Q. Wu, B. Xiao, J. Zhu, and J. U. Lindgren. 2001. Adjuvant-induced arthritis: IL-1β, IL-6 and TNF-α are up-regulated in the spinal cord. NeuroReport 12: 3905-3908.
32. Mihara, M., N. Nishimoto, K. Yoshizaki, and T. Suzuki. 2002. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice. Immunol. Lett. 84: 223-229.
33. Li, H., S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
34. Eisenbarth, S. C., O. R. Colegio, W. O'Connor, F. S. Sutterwala, and R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
35. Venge, J., M. Lampinen, L. Hakansson, S. Rak, and P. Venge. 1996. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J. Allergy Clin. Immunol. 97: 1110-1115.
36. Rothenberg, M. E. 1999. Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21: 291-295.
37. Herz, U., A. Braun, R. Ruckert, and H. Renz. 1998. Various immunological phenotypes are associated with increased airway responsiveness. Clin. Exp. Allergy. 28: 625-634.
38. Coffman, R. L., J. Ohara, M. W. Bond, J. Carty, A. Zlotnik, and W. E. Paul. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharideactivated B cells. J. Immunol. 136: 4538-4541. (Pubitemid 16090673)
39. Vitetta, E. S., J. Ohara, C. D. Myers, J. E. Layton, P. H. Krammer, and W. E. Paul. 1985. Serological, biochemical, and functional identity of B cellstimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 162: 1726-1731.
40. Rincon, M., J. Anguita, T. Nakamura, E. Fikrig, and R. A. Flavell. 1997. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 185: 461-469.
41. Diehl, S., T. Krahl, L. Rinaldi, R. Norton, C. G. Irvin, and M. Rincon. 2004. Inhibition of NFAT specifically in T cells prevents allergic pulmonary inflammation. J. Immunol. 172: 3597-3603. (Pubitemid 38337941)
42. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, 3rd, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
43. Pene, J., J. F. Gauchat, S. Lecart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. C. Lecron, and H. Yssel. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172: 5154-5157.
44. Suto, A., H. Nakajima, K. Hirose, K. Suzuki, S. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D. C. Foster, and I. Iwamoto. 2002. Interleukin 21 prevents antigeninduced IgE production by inhibiting germ line Cε transcription of IL-4-stimulated B cells. Blood 100: 4565-4573.
45. Kishida, T., Y. Hiromura, M. Shin-Ya, H. Asada, H. Kuriyama, M. Sugai, A. Shimizu, Y. Yokota, T. Hama, J. Imanishi, Y. Hisa, and O. Mazda. 2007. IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J. Immunol. 179: 8554-8561.
46. Rogers, D. F. 2004. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr. Opin. Pharmacol. 4: 241-250.
47. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
48. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796-3806.
49. Marini, M., E. Vittori, J. Hollemborg, and S. Mattoli. 1992. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89: 1001-1009.
50. Kicic, A., E. N. Sutanto, P. T. Stevens, D. A. Knight, and S. M. Stick. 2006. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am. J. Respir. Crit. Care Med. 174: 1110-1118.
51. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89: 958-967.
52. Tillie-Leblond, I., J. Pugin, C. H. Marquette, C. Lamblin, F. Saulnier, A. Brichet, B. Wallaert, A. B. Tonnel, and P. Gosset. 1999. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 159: 487-494. (Pubitemid 29084870)
53. Stankiewicz, W., M. P. Dabrowski, A. Chcialowski, and T. Plusa. 2002. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediators Iinflamm. 11: 307-312.
54. Dixon, A. E., D. M. Raymond, B. T. Suratt, L. M. Bourassa, and C. G. Irvin. 2008. Lower airway disease in asthmatics with and without rhinitis. Lung 186: 361-368.
55. Agrawal, A., S. Rengarajan, K. B. Adler, A. Ram, B. Ghosh, M. Fahim, and B. F. Dickey. 2007. Inhibition of mucin secretion with MARCKS-related peptide improves airway obstruction in a mouse model of asthma. J. Appl. Physiol. 102: 399-405.
56. Voynow, J. A., and B. K. Rubin. 2009. Mucins, mucus, and sputum. Chest 135: 505-512.
57. Chen, Y., P. Thai, Y. H. Zhao, Y. S. Ho, M. M. DeSouza, and R. Wu. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278: 17036-17043.
58. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342.
59. Dienz, O., and M. Rincon. 2009. The effects of IL-6 on CD4 T cell responses. Clin. Immunol. 130: 27-33.
60. Holland, S. M., F. R. DeLeo, H. Z. Elloumi, A. P. Hsu, G. Uzel, N. Brodsky, A. F. Freeman, A. Demidowich, J. Davis, M. L. Turner, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619.
61. Minegishi, Y., M. Saito, S. Tsuchiya, I. Tsuge, H. Takada, T. Hara, N. Kawamura, T. Ariga, S. Pasic, O. Stojkovic, A. Metin, and H. Karasuyama. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058-1062.